World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
119
Citations
78822
World Ranking
335
National Ranking
210

Medicine

D-Index
119
Citations
78915
World Ranking
3817
National Ranking
2092

Thomas F. Gajewski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas F. Gajewski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 527 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas F. Gajewski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Gajewski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 119 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Thomas F. Gajewski is affiliated with the University of Chicago in the United States. Their research focuses primarily on Medicine, with significant contributions in Immunology and Microbiology. The subfields of study include Oncology, Immunology, Infectious Diseases, Molecular Biology, and Pulmonary and Respiratory Medicine.

Their work revolves around several main topics:

  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • Melanoma and MAPK Pathways

Thomas F. Gajewski has published extensively in various scientific venues. The most frequent publication venues include:

  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Cancer Immunology Research
  • bioRxiv (Cold Spring Harbor Laboratory)

Some of their recent papers are:

  • "Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy" (2020) published in Gastroenterology
  • "Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma" (2022) published in Journal of Clinical Oncology
  • "CXCL9 and CXCL10 bring the heat to tumors" (2022) published in Science Immunology
  • "Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma" (2021) published in Journal of Clinical Oncology
  • "Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma" (2021) published in Journal for ImmunoTherapy of Cancer

Frequent collaborators include:

  • Emily F. Higgs
  • Sherin J. Rouhani
  • Jonathan Trujillo
  • Yuanyuan Zha
  • Alexandra Cabanov

Thomas F. Gajewski holds membership in the Association of American Physicians. This affiliation represents a recognition within the medical research community.

Best Publications

  • Innate and adaptive immune cells in the tumor microenvironment

    Thomas F. Gajewski;Hans Schreiber;Yang Xin Fu

  • Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

    Ayelet Sivan;Leticia Corrales;Nathaniel Hubert;Jason B. Williams

  • The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients

    Vyara Matson;Jessica Fessler;Riyue Bao;Tara Chongsuwat

  • Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

    Stefani Spranger;Riyue Bao;Thomas F. Gajewski

  • Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

    Nadeem Riaz;Jonathan J. Havel;Vladimir Makarov;Alexis Desrichard

  • STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors

    Liufu Deng;Hua Liang;Meng Xu;Xuanming Yang

  • Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.

    Stefani Spranger;Robbert M. Spaapen;Yuanyuan Zha;Jason Williams

  • STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

    Seng Ryong Woo;Mercedes Beatriz Fuertes;Leticia Corrales;Stefani Spranger

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

    Leticia Corrales;Laura Hix Glickman;Sarah M. McWhirter;David B. Kanne

  • Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy

    Antoni Ribas;Reinhard Dummer;Igor Puzanov;Ari VanderWalde

  • Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

    Stefani Spranger;Daisy Dai;Brendan Horton;Thomas F. Gajewski

  • Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

    Mercedes B. Fuertes;Aalok K. Kacha;Justin Kline;Seng Ryong Woo

  • Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

    Helena Harlin;Yuru Meng;Amy C. Peterson;Yuanyuan Zha

  • Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

    T F Gajewski;F W Fitch

  • Helper T Cell Differentiation Is Controlled by the Cell Cycle

    Jennifer J. Bird;Daniel R. Brown;Alan C. Mullen;Naomi H. Moskowitz

  • Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

    Georgina V Long;Reinhard Dummer;Omid Hamid;Thomas F Gajewski

  • PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells

    Christian Blank;Ian Elliott Brown;Amy C. Peterson;Mike Spiotto

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.

    Christian Blank;Thomas F. Gajewski;Andreas Mackensen

Frequent Co-Authors

Jason J. Luke
Jason J. Luke University of Pittsburgh
F. Stephen Hodi
F. Stephen Hodi Harvard University
Antoni Ribas
Antoni Ribas University of California, Los Angeles
Igor Puzanov
Igor Puzanov Roswell Park Cancer Institute
Frank W. Fitch
Frank W. Fitch University of Chicago
Theodore Karrison
Theodore Karrison University of Chicago
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Pierre Coulie
Pierre Coulie Université Catholique de Louvain
Maria-Luisa Alegre
Maria-Luisa Alegre University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding your expertise through related nursing fields can open diverse career opportunities. Many professionals turn to nurse practitioner programs that complement immunological knowledge, especially in specialized areas like psychiatric mental health.

If you're exploring options, researching the easiest np programs to get into can help you find accessible pathways to advance your nursing credentials without overwhelming admission criteria.

Online learning has made it easier to balance education with career demands. For instance, the best pmhnp programs online stand out for their strong clinical placement rates, providing essential hands-on experience alongside theoretical knowledge.

Cost is another important consideration. Finding cheapest pmhnp programs ensures you can pursue advanced studies without excessive financial strain, making these degrees more accessible for many students.

Career prospects also depend on location. Exploring the dnp salary by state can help you understand potential earnings after completing a Doctor of Nursing Practice degree, guiding your career decisions based on regional opportunities and compensation trends.

Best Scientists Citing Thomas F. Gajewski

Trending Scientists

Recently Published Articles